METTL1 and central nervous system cancer: More recent functional evidence indicates that METTL1 drives glioma development through m7G‐dependent modification and stabilization of the glycolytic enzyme PGK1 mRNA, which enhances glycolytic activity, promotes cellular proliferation and accelerates tumour growth in vivo.71